Table:
begin	end	state
1	37	cytoplasmic
38	58	transmembrane
59	66	non-cytoplasmic
67	88	transmembrane
89	109	cytoplasmic
110	135	transmembrane
136	157	non-cytoplasmic
158	178	transmembrane
179	187	cytoplasmic
188	210	transmembrane
211	232	non-cytoplasmic
233	254	transmembrane
255	270	cytoplasmic
271	293	transmembrane
294	318	non-cytoplasmic
319	341	transmembrane
342	368	cytoplasmic
369	389	transmembrane
390	394	non-cytoplasmic
395	416	transmembrane
417	427	cytoplasmic
428	447	transmembrane
448	452	non-cytoplasmic
453	472	transmembrane
473	483	cytoplasmic

Input:
>CCNA_00435
MVGGTPKVSFWTRRKAIDTITAGHADSHQLKKTLSWPHLVALGVGAIVGTGIYTLTGVGA
GLAGPGVILSFLIAGAVCACAALCYAELSTMIPASGSAYTYSYAAMGEPVAWFVGWSLIL
EYTLVCAAVAVGWSAHAHGLFKMIGFPDALLAGPHQGGLINMPAVFISMAVAGLLALGTR
ESATVNMVLVFVKIIALIVFVVLCLPAFNLAHFTPFMPNGFQAHVPEGAAADAAKVGVMA
AASLIFFAFYGFDAVSTAAEETKNPKRDLTIGIVGSMAVCTAIYMIVAAVSIGASRTEVF
SKSEAPLVFILESLNHGKIAQLVALAAVIALPTVILAFMYGQSRIFFVMARDGLLPRALS
KVNAKTGTPVMMTLLTGVLAAVISGLLSLKDIAELANAGTLWAFIAVGASVILLRLREPN
RPRVFSTPLWPIVAPAGILGCLYLFLSLPGKTQLYFLYAHLIGAVVYLAYGMRKSVLAQQ
ERA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server